ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,811Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 1187

$1.66M Total Retail Price of All Prescriptions

Rank: 7 out of 1187

735 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 20,814 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 890 834 1 2
ATORVASTATIN CALCIUM 629 576 2 6
OMEPRAZOLE 610 572 3 5
CARVEDILOL 571 532 4 19
SIMVASTATIN 546 508 5 1
METOPROLOL SUCCINATE 501 442 6 11
GLIMEPIRIDE 497 448 7 30
CRESTOR 464 432 8 16
METFORMIN HCL 437 395 9 7
ZOLPIDEM TARTRATE 425 396 10 14
NEXIUM 404 348 11 15
LISINOPRIL 379 339 12 4
DIOVAN 339 318 13 17
DONEPEZIL HCL 332 332 14 26
NAMENDA 329 329 15 44
LEVOTHYROXINE SODIUM 300 250 16 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 299 261 17 39
DIOVAN HCT 297 263 18 40
ALENDRONATE SODIUM 284 263 19 25
FUROSEMIDE 283 265 20 8
CLOPIDOGREL 265 235 21 33
PLAVIX 237 209 22 52
CLONIDINE HCL 231 209 23 73
JANUVIA 225 214 24 34
TAMSULOSIN HCL 215 193 25 29
WARFARIN SODIUM 196 180 26 13
METOPROLOL TARTRATE 194 194 27 10
FAMOTIDINE 191 173 28 48
SERTRALINE HCL 185 174 29 22
LIPITOR 183 166 30 43
RAMIPRIL 180 172 31 36
NAPROXEN 175 145 32 72
EVISTA 157 154 33 114
GABAPENTIN 150 143 34 23
MECLIZINE HCL 148 140 35 112
LOSARTAN POTASSIUM 141 132 36 21
SPIRONOLACTONE 141 115 36 98
MELOXICAM 141 118 36 49
LEVOCETIRIZINE DIHYDROCHLORIDE 139 91 39 166
ISOSORBIDE MONONITRATE ER 133 114 40 66
PROAIR HFA 129 93 41 41
METFORMIN HCL ER 129 103 41 57
ALLOPURINOL 126 125 43 50
ENALAPRIL MALEATE 120 120 44 27
MIRTAZAPINE 119 100 45 54
DIVALPROEX SODIUM 118 118 46 79
HYDROCHLOROTHIAZIDE 117 102 47 9
HYDROCODONE-ACETAMINOPHEN 114 110 S3 48 20
LIDODERM 114 102 48 80
PANTOPRAZOLE SODIUM 112 111 50 42
LOVAZA 106 93 51 53
MEGESTROL ACETATE 105 104 R 52 185
CITALOPRAM HBR 103 102 53 45
BENICAR HCT 102 89 54 170
LOSARTAN-HYDROCHLOROTHIAZIDE 100 95 55 56
EXELON 99 99 56 132
NATEGLINIDE 98 98 57 192
FLUTICASONE PROPIONATE 96 90 58 31
CELEBREX 95 79 59 68
CIPROFLOXACIN HCL 95 86 59 84
SPIRIVA 91 76 61 55
SINGULAIR 91 67 61 67
DIGOXIN 90 90 63 65
TRAMADOL HCL-ACETAMINOPHEN 89 87 64 102
DEXILANT 88 64 65 137
VENLAFAXINE HCL ER 88 88 65 121
POTASSIUM CHLORIDE 88 81 65 32
LACTULOSE 85 83 68 96
AMLODIPINE BESYLATE-BENAZEPRIL 84 84 69 62
FENOFIBRATE 83 64 70 88
CLARITHROMYCIN 83 74 70 257
AZITHROMYCIN 83 77 70 24
VOLTAREN 82 80 73 126
ADVAIR DISKUS 81 67 74 35
ZETIA 79 79 75 64
KETOCONAZOLE 78 69 76 181
OXYCODONE-ACETAMINOPHEN 78 57 S2 76 47
SYNTHROID 78 78 76 46
CARBIDOPA-LEVODOPA 77 77 79 99
TRILIPIX 77 77 79 154
CLOTRIMAZOLE-BETAMETHASONE 76 60 81 100
LANSOPRAZOLE 75 75 82 172
BYSTOLIC 74 74 83 116
BENICAR 73 73 84 125
ONGLYZA 71 68 85 169
DICLOFENAC SODIUM 71 66 85 162
ACTOS 70 54 87 101
TRAMADOL HCL 68 61 88 28
ATENOLOL 67 55 89 18
TRIAMCINOLONE ACETONIDE 66 60 90 184
PRAVASTATIN SODIUM 65 58 91 12
POLYETHYLENE GLYCOL 3350 64 61 92 86
PAROXETINE HCL 64 55 92 81
CYCLOBENZAPRINE HCL 64 56 R 92 87
GLIPIZIDE XL 60 48 95 117
PRANDIN 60 49 95 139
LANTUS 59 41 97 77
SPS 58 58 98 282
IBUPROFEN 57 57 99 59
PRADAXA 57 57 99 199
TRICOR 56 38 101 94
BENAZEPRIL HCL 55 55 102 142
CEPHALEXIN 55 51 102 176
NIASPAN 55 55 102 145
INSULIN SYRINGE 54 44 105 128
DICYCLOMINE HCL 54 30 105 241
METHOTREXATE 53 53 107 394
NOVOLOG 53 51 107 135
CYMBALTA 52 49 109 60
LEXAPRO 50 49 110 258
TORSEMIDE 50 50 110 160
PROCTOZONE-HC 50 50 110 311
VESICARE 50 50 110 176
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.